Latest news
Nasus Pharma (NSRX) Stock Forecast and Price Target 2026 - MarketBeatMarketBeat · Sun, 09 Aug 2026 12:12:31 GMTNumber of employees of Nasus Pharma Ltd. – AMEX:NSRX - TradingViewTradingView · Sun, 09 Aug 2026 06:30:32 GMTNasus Pharma (NSRX) Advances 1.81%: Testing Key Resistance at $3.55 - Protective Put - dars.gov.etdars.gov.et · Thu, 06 Aug 2026 19:44:10 GMTNasus Pharma (NSRX) CEO Dan Teleman resigns as CEO and director - Stock TitanStock Titan · Wed, 29 Jul 2026 21:00:38 GMTNasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth - The Manila TimesThe Manila Times · Tue, 28 Jul 2026 11:36:40 GMTNasus Pharma Ltd (NSRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKeyTradingKey · Mon, 27 Jul 2026 18:18:35 GMTNasus Pharma Ltd (NSRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKeyTradingKey · Mon, 27 Jul 2026 09:36:28 GMTNSRX|Nasus Pharma Ltd|Price:3.030|Chg%:+0.020 - TradingKeyTradingKey · Mon, 27 Jul 2026 00:49:45 GMT